Skip to main content
. 2023 Jan 20;56:101824. doi: 10.1016/j.eclinm.2023.101824

Fig. 4.

Fig. 4

Fig. 4

Radar plot for pointed estimates of the likelihood of being helped or harmed for progression-free survival and overall survival for palbociclib [A], ribociclib [B] and abemaciclib [C]. Values are displayed on logarithmic scale. Results from the random-effects model were used to compute the LHHs. Higher values correlate to a greater likelihood to benefit than to harm and are plotted closer to the external ring. G = grade, PFS = progression-free survival, OS = overall survival.